Cytek Biosciences, Inc. Common Stock CTKB
$4.05
-3.34%
at last close
Financials (TTM)
- Revenue
- $204.17 million
- Net Income
- $-74,003,000
- Net Margin
- -36.25%
- Return on Equity
- -22.59%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.65
- Price / Sales
- 2.65
Over the trailing twelve months, Cytek Biosciences, Inc. Common Stock generated revenue of $204.17 million and net income of $-74,003,000, a net margin of -36.25%.
At the last closing price of $4.05, CTKB trades at 2.65 times sales, with a market capitalization of $541.11 million.
Key Stats
- Last Close
- $4.05
- Market Cap
- $541.11 million
- 52-Week Range
- $2.37 – $6.18
- Average Volume
- 932K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.